Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;29(5):433-41.
doi: 10.1007/s10557-015-6619-0.

Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program

Affiliations

Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program

Alan Sugrue et al. Cardiovasc Drugs Ther. 2015.

Abstract

Introduction: Initiation of class III anti-arrhythmic medications requires telemetric monitoring for ventricular arrhythmias and QT prolongation to reduce the risk of torsades de pointes (TdP). Heart rate-corrected QT interval (QTc) is an indicator of risk, however it is imperfect, and subtle abnormalities of repolarization have been linked with arrhythmogenesis.

Purpose: Identification of electrocardiographic predictors of torsadogenic risk through the application of a novel T wave analysis tool.

Methods: Among all patients admitted to Mayo Clinic for initiation of dofetilide or sotalol, we identified 13 cases who developed drug-induced TdP and 26 age and sex matched controls that did not develop TdP. The immediate pre-TdP ECG of those with TdP was compared to the last ECG performed prior to hospital discharge in controls using a novel T wave program that quantified subtle changes in T wave morphology.

Results: The QTc and 12 T wave parameters successfully distinguished TdP cases from controls. The top performing parameters were the QTc in lead V3 (mean case vs control 480 vs 420 msec, p < 0.001, r = 0.72) and T wave right slope in lead I (mean case vs control -840.29 vs -1668.71 mV/s, p = 0.002, r = 0.45). The addition of T wave right slope to QTc improved prediction accuracy from 79 to 88 %.

Conclusion: Our data demonstrate that, in addition to QTc, the T wave right slope is correlated strongly with TdP risk. This suggests that a computer-based repolarization measurement tool that integrates additional data beyond the QTc may identify patients with the greatest torsadogenic potential.

Keywords: Class III antiarrhythmics; Electrocardiography; Risk stratification; T wave analysis; Torsade de pointes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROC classification of the ECG features A. ROC curve for QTc, AUC= 0.8096 B. ROC curve for T wave right slope. AUC =0.6442 C. ROC curve for QTc and T wave right slope. AUC =0.8750 Comparison of mean values of Lead V3 - QTc and Lead I - T wave right slope, cases vs controls. This is data analysed from the ECG closest to the Tdp event (case) or dismissal (control)
Figure 1
Figure 1
ROC classification of the ECG features A. ROC curve for QTc, AUC= 0.8096 B. ROC curve for T wave right slope. AUC =0.6442 C. ROC curve for QTc and T wave right slope. AUC =0.8750 Comparison of mean values of Lead V3 - QTc and Lead I - T wave right slope, cases vs controls. This is data analysed from the ECG closest to the Tdp event (case) or dismissal (control)
Figure 2
Figure 2
ECG average tracings and box plots. Above, QTc (synchronised by Q wave), below T wave right slope (synchronised by T wave)
Figure 3
Figure 3
A - ECG from Tdp case. This highlights a shallow T wave right slope, especially visible in Lead I (when compared to ECG of age and sex match control of Figure 3 B) B - ECG from age and sex matched control. Note the T wave right slope is steeper when compared to Figure 3A (Tdp case).
Figure 3
Figure 3
A - ECG from Tdp case. This highlights a shallow T wave right slope, especially visible in Lead I (when compared to ECG of age and sex match control of Figure 3 B) B - ECG from age and sex matched control. Note the T wave right slope is steeper when compared to Figure 3A (Tdp case).

Comment in

Similar articles

Cited by

References

    1. Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation. 2012;125(2):381–389. - PubMed
    1. Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Journal of the American College of Cardiology. 2010;55(9):934–947. - PMC - PubMed
    1. Lehmann MH, Hardy S, Archibald D, quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation. 1996;94(10):2535–2541. - PubMed
    1. Soyka LF, Wirtz C, Spangenberg RB. Clinical safety profile of sotalol in patients with arrhythmias. The American journal of cardiology. 1990;65(2):74A–81A. discussion 2A–3A. - PubMed
    1. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. The New England journal of medicine. 1999;340(24):1855–1862. - PubMed

Publication types